updates Editorial Review - Biomarkers Journal The editorial discusses the content of eight abstracts from the "17th Annual Biomarkers and Personalised Medicine in Cardiovascular Disease Symposium," published in Biomarkers. These abstracts touch on various aspects of
blog Revolutionizing Medical Diagnostics: Innovations and Challenges Carlsbad, CA (August 10, 2023) - RCE Technologies, Inc. In the dynamic world of medical research, the quest for accurate diagnostics remains an ever-evolving endeavor. Dr. Frank Peacock, a distinguished
press RCE.ai Selected as a Promising Health Tech Company in the Cedars-Sinai Accelerator Program Carlsbad, CA (July 11, 2023) - RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection
research Nature Review - Cardiology Carlsbad, California (May 1, 2023) - RCE Technologies, Inc. RCE's technology was recognized in the cardiology research highlights from the review conducted and published in the world’s preeminent scientific
research JAMA News and Analysis Carlsbad, California (April 24, 2023) - RCE Technologies, Inc. RCE's technology was recently featured in the latest release of the globally acclaimed Journal of the American Medical Association (JAMA) magazine.
press Detecting Heart Attacks In Cardiac Arrest Patients Carlsbad, California (April 11, 2023) - RCE Technologies, Inc. Heart disease is a leading cause of death worldwide, and heart attacks are a particularly dangerous form of heart disease. When
research European Heart Journal - Digital Health (Editorial Review) Carlsbad, California (May 1, 2023) - RCE Technologies, Inc. Esteemed editors at the European Heart Journal (EHJ) - Digital Health reviewed the recently published work ‘A novel breakthrough in wrist-worn
updates Beyond the Data: A Wrist-Worn Sensor in Chest Pain Workup Carlsbad, California (March 27, 2023) - RCE Technologies, Inc. Check out the Professor Mamas Mamas's recent interview with Dr. Partho Sengupta. Dr. Sengupta emphasizes the value of continuous biomarkers, the
updates RCE at the 17th Annual Biomarkers Symposium Torrey Pines, California (March 25, 2023) The 17th Annual Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium showcased the latest clinical data, guidelines and evidence related to the clinical application
research A novel breakthrough in wrist-worn transdermal troponin-I-sensor assessment for acute myocardial infarction Carlsbad, California (March 19, 2023) - RCE Technologies, Inc. Download PDF
blog X-ray to CT-Scan and beyond.. March 14, 2023 | RCE.ai Significant developments and evolution of medical device technology have occurred in many fields of medicine. One such area was radiology, and studying history helps us
research Early Changes in Acute Myocardial Infarction in Pigs: Achieving Early Detection with Wearable Devices Carlsbad, California (March 9, 2023) - RCE Technologies, Inc. Download PDF This research paper was published on MDPI About RCE: RCE, an AI based med tech works towards the early
press RCE Takes the Stage at the 2023 American College of Cardiology with Exciting Late Breaking Clinical Trial Results New Orleans, LA (March 6, 2023) - RCE Technologies, Inc's groundbreaking study titled "A Novel Breakthrough In Wrist-Worn Transdermal Troponin-I-Sensor Assessment For Acute Myocardial Infarction" was presented at the American
press RCE welcomes Ronald P. Karlsberg, MD as clinical advisor Carlsbad, California (March 2, 2023) - RCE Technologies, Inc. has just announced a major addition to the clinical team: the highly acclaimed Ronald P. Karlsberg, MD, FACC. As a Clinical
research RCE awarded NSF grant to advance development of heart attack diagnostics Carlsbad, California (January 16, 2023) - RCE Technologies, Inc. a medical technology company harnessing the power of sensors, machine learning and proprietary algorithms towards heart attack diagnostics, announced today it
press RCE to present at the 2023 American College of Cardiology - Late Breaking Clinical Trials Carlsbad, California (December 20, 2022) - RCE Technologies, Inc. has been accepted to present at the American College of Cardiology - Late Breaking Clinical Trials. The presentation titled, "A Novel
research American Heart Association 2022 - RCE presentation RCE had the honor to present a poster in “The Intersection of Biomarkers and Health Technology '' session series at the American Heart Association's 2022 conference in Chicago this November.
press RCE featured at innovation showcase September 14, 2022 | New Brunswick, NJ With rapid transformation of cardiovascular medicine from reactive to preventive, the Rutgers Robert Wood Johnson University Hospital is investing in the vision of a
research Exploration of a transdermal screening tool in the emergency department setting The clinical team at University of Texas Southwestern (UTSW) presented insights from a pilot study done back in 2021 work, that compared the Tropsensor with blood based measurements in patients
research Abstract presentation at the Gordon Research Conference 2022 July 18, 2022 | Ventura, CA RCE in collaboration with Texas Heart Institute's research team, is thrilled with the opportunity to have presented the poster titled: "A Novel Telemedicine Platform for
blog How we found a potential confounder May 13, 2022 | Mike Kim Testing is usually perceived as the activity performed AFTER development is complete. If you’re familiar with the medical device industry, you probably heard about
press RCE secures its milestone patent Feburary 22, 2022 | Carlsbad, CA RCE, the AI med tech company developing point of care Troponin diagnostics, has announced the award of its first patent from the U. S. Patent
blog Fostering Creativity, Not Stifling It. Feb 19, 2022 | Atandra Burman Creativity is the act of conceiving something new, while Innovation is the act of putting that something new in practice. In other words, innovation is
blog Value of Troponin in the absence of ischemic symptoms and ECG in non-cardiac surgeries With over 300 million non-cardiac surgeries worldwide each year, more than 10 million patients develop major cardiac complications in the "perioperative" period. ie. within 30 days after non-cardiac surgeries. Perioperative
